Cytovation
PrivateLast Round
Series A
Extension
Apr 23, 2025
Total Funding Raised
$34M
Momentum Score
25 /100
Company Overview
Cytovation ASA is a clinical-stage biotech company that develops treatments for solid tumors in oncology and rare diseases.
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cytovation Comps
Public and private peers based on sector, stage, and business model.
Cytovation Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Apr 23, 2025 | ||||
| Series A Extension | Jun 2, 2023 | ||||
| Series A | Jan 25, 2022 | ||||
| Private Placement | Jan 8, 2018 | ||||
| Private Placement | Jun 29, 2017 |
Key People
Founding team and executive leadership
Cytovation Investors
Notable investors and investment history
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 19, 2026
Monthly visitors grew 669% MoM, reaching 3.2K.
- Apr 23, 2025
$6M round led by Sandwater.
Cytovation Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Cytovation's valuation, stock price, and market status.
Firmographic Details
HeadquartersBergen
Employee Range13
Year Founded2001
Last FundingApr 23, 2025
